Delivery Order SPE2DR25D3004-SPE2DR26FXVR3
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $9,442.36 to AmerisourceBergen Drug Corp for the supply of Depakote DR 125 mg Sprinkle Capsules (100-count) on December 18, 2025, with an ultimate completion date of December 19, 2025. This is a firm fixed price, non-set-aside contract performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a competitive award under the company's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order valued at $2,515.48 to AmerisourceBergen Drug Corp for the supply of Depakote DR 125 mg Sprinkle capsules (100 count) on January 13, 2026, with an ultimate completion date of January 14, 2026. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and...
- This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is a delivery order valued at $2,227.26 for the provision of 4,568,439,684 Depakote DR 500 MG tablets. The contract is a firm fixed-price, non-set-aside award with a completion date of June 4, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00,...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 4,557,971 units of Depakote DR 125 mg capsules, a medication used to treat seizures, bipolar disorder, and migraines. The firm-fixed-price contract has a ceiling value of $1,958.77 and was awarded on August 2, 2022, with an ultimate completion date of August 3, 2022. This delivery order is a part of a larger Indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Depakote DR 125 mg sprinkle capsules (100-count unit) valued at $1,458.55. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The award utilized firm fixed pricing with no set-aside designation, reflecting...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,207.01 firm fixed-price delivery order is for the supply of 4,568,106,903 units of the medication Depakote DR 125 mg sprinkle capsules. The contract has a performance period through May 2, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,711.55, is a Firm Fixed Price Delivery Order for the supply of Depakote DR 125 mg sprinkle capsules. The contract has a performance period through March 13, 2025 and does not have a set-aside designation. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) valued at $999,999,999...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,548,337 units of the medication Depakote DR 125 mg sprinkle capsules, with an ultimate completion date of June 16, 2025 and a ceiling value of $2,055.23. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition....
- Amerisourcebergen Drug Corporation, operating as Amerisourcebergen, has been awarded a firm fixed price delivery order valued at approximately $3,000 by the Defense Logistics Agency Troop Support Medical to provide 250mg tablets of the anti-epileptic drug Depakote ER. Performance will take place in Conshohocken, Pennsylvania under a one-day period concluding on July 11, 2023. The Defense Logistics Agency Troop Support Medical supports the medical readiness of the armed forces through procurement...
- This federal contract award is for the delivery of 100 bottles of Depakote DR 125 mg sprinkle capsules to the Defense Logistics Agency (DLA). The $4,505.10 firm fixed-price delivery order was issued to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of January 11, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DR25D3004Indefinite Delivery Contract
- SPE2DR25D3004-SPE2DR26FXVR3Delivery Order
AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order by the Defense Logistics Agency (DLA) on January 27, 2026, for $2,007.78 to supply Depakote DR 500 mg tablets (100-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and a completion date of January 28, 2026. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (valued at $999,999,999.00 through December 2026), which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs. The DLA's pharmaceutical procurement through this contract vehicle supports critical medical needs across the Department of Defense healthcare system. Depakote (divalproex sodium) is a neurological and psychiatric medication commonly used to treat seizure disorders, bipolar disorder, and migraines, making this a typical pharmaceutical commodity within the DLA's broader medical supply chain. AmerisourceBergen's established role as a major pharmaceutical distributor and its demonstrated capability to fulfill federal medical procurement requirements through competitive contracting positions the company to efficiently deliver essential medications to military treatment facilities and other government healthcare systems worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 1/26/26 |